Title : Kallikrein-related peptidase (KLK10) cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathway.

Pub. Date : 2020 Jul

PMID : 32386481






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 More important, preconditioning with PI3K/AKT inhibitor LY294002 or mTOR inhibitor rapamycin both aggravated KLK10 knockdown-suppressed cancer cell growth and glucose metabolism. Sirolimus kallikrein related peptidase 10 Homo sapiens